Autopsy report · NCT01398124

Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer

“We will not be pursuing this study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Milton S. Hershey Medical Center

Sponsor type

University, hospital or other

Conditions

Non-small Cell Lung Cancer

Interventions

Cyclin B1 Peptide

Participants

0

Trials that died the same way

• Study of Body Composition Methodology in Young Children (InfantPod)
  “This study will not be conducted. A new study is replacing this one.” (74% match in meaning)
• Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
  “The study team decided not to pursue this study.” (72% match in meaning)
• Noninvasive Positive Pressure Ventilation for Early Extubation of Acute Hypoxemic Respiratory Failure
  “We anticipated that we could not complete this study.” (71% match in meaning)
• Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
  “No funding, time, or personnel to complete this study.” (68% match in meaning)
• A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
  “This study will not be proceeding due to lack of funding from anticipated sources” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.